Skip to content
Search

Latest Stories

Warner ready to return from retirement for India Test series

Warner, who accumulated 8,786 runs in 112 Tests, has recently played in limited-overs franchise competitions in Canada and the Cayman Islands.

Warner, who retired after the third Test against Pakistan in Sydney in January, has told Australian coach Andrew McDonald that he can step in if needed. (Photo: Getty Images)
Warner, who retired after the third Test against Pakistan in Sydney in January, has told Australian coach Andrew McDonald that he can step in if needed. (Photo: Getty Images)

DAVID Warner has informed Australian selectors that he is available to come out of retirement and play in the upcoming home Test series against India. The five-match Border-Gavaskar Trophy is set to begin in Perth on November 22.

The 37-year-old batsman said he is "dead serious" about his offer to return, particularly with Steve Smith aiming to move back to his preferred number four position, which leaves the selectors searching for an opening partner for Usman Khawaja.


Warner, who retired after the third Test against Pakistan in Sydney in January, has told Australian coach Andrew McDonald that he can step in if needed. However, McDonald appears less enthusiastic about the idea.

"I'm always available, just got to pick up the phone," Warner told News Corp on Tuesday. He suggested he could be a stronger option than players who have only just started their domestic Sheffield Shield season.

"I'm always dead serious. Let's be honest, the guys have played one red-ball game since their last Test matches in February, so I've almost had the same preparation. Honestly, if they really needed myself for this series, I’m more than happy to play the next Shield game and go out there and play."

Warner also noted McDonald’s response to his offer didn't indicate a recall was likely. "His answer back to me was, 'you retired'," Warner said. "I don't think he wants to give me the pleasure of him saying: Can you come back?"

Warner, who accumulated 8,786 runs in 112 Tests, has recently played in limited-overs franchise competitions in Canada and the Cayman Islands.

Meanwhile, Cameron Bancroft, Marcus Harris, and Matthew Renshaw are seen as contenders to open alongside Khawaja in the series against India.

(With inputs from AFP)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less